Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Livea Tirzepatide Review: Cost, 15+ Years Established & Honest Verdict (2026)

An honest 2026 review of Livea tirzepatide — a genuine LegitScript seal, a real regional clinic history since 2011, but only 4 states served.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

MadeMed

One flat tirzepatide price published dose by dose, from 2.5mg all the way to 15mg.

$399/mo (quarterly plan)

Check MadeMed availability

Livea has a genuine LegitScript certification and $99/month semaglutide pricing — a real, established regional clinic network rather than a pure telehealth startup. Every fact here comes from the company's own published program.

What Livea is

Livea is a physician-supervised medical weight-loss clinic, founded in 2011 with 8 physical clinics in Minnesota and Wisconsin, plus telehealth in MN, WI, Iowa, and Florida. LegitScript certified. It's physician-owned (Livea Medical PLLC) with a named Medical Director, Dr. Paul Olson, in internal medicine/nephrology with 40 years of experience.

§ Livea — 15+ Years Established, 4-State Reach

ItemDetail
Founded2011
LegitScriptCertified
Telehealth statesMN, WI, IA, FL only —
Verified: LegitScript certified, $99/mo semaglutide. Founded 2011, 4 states served, 50,000+ clients.

What Livea costs

Compounded semaglutide starts from $99/month. Tirzepatide starts from $199/month — significantly cheaper than brand Ozempic/Wegovy self-pay rates of $1,000+/month. A separate $69/month program fee may apply on top, bringing the effective total closer to $168/month for the GLP-1 component.

A real, established track record

This is a genuine differentiator: 15+ years established (founded 2011), 50,000+ clients served, and voted Minnesota's Best Weight Loss Program 5 consecutive years — a substantially longer and more independently recognized track record than most telehealth-only competitors on this site.

Only 4 states served

Livea's telehealth reach is limited to 4 states — Minnesota, Wisconsin, Iowa, and Florida — a genuinely narrow footprint compared to the nationwide competitors elsewhere on this site. It remains primarily a regional clinic network.

The brand-vs-compounded question

Livea dispenses compounded tirzepatide — pharmacy-made, not itself an FDA-approved finished drug, and not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture — compounded tirzepatide availability specifically may be affected by the FDA's 2026 shortage-end announcement, subject to eligibility.

How the care model holds up

Livea's real strengths, and is a genuine LegitScript certification, physician-owned structure with a named, credentialed Medical Director, a 15+ year established track record with 50,000+ clients and independent regional recognition, and a comprehensive program — InBody scans, registered dietitian counseling, health coaching, and regular provider check-ins — all bundled in. The trade-offs: telehealth is limited to just 4 states, pricing is somewhat ambiguous once the separate program fee is factored in, labs aren't explicitly included in every tier, and its telehealth reach into Iowa and Florida is newer and less established than its core Minnesota/Wisconsin clinic markets. As with any GLP-1 program, confirm your state's eligibility first given the narrow footprint; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Livea's genuine 15-year track record, physician ownership, and comprehensive dietitian-and-coaching program set it apart from most telehealth-only competitors on this site — real, confirmed strengths. Just check your state first, since coverage is limited to Minnesota, Wisconsin, Iowa, and Florida. If you're outside that footprint, compare it against BiltRx or Elara Health and Wellness, which offer similarly bundled coaching nationwide. Another named-founder, NP-led practice worth comparing is Luma Health Co. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through Livea?

From $199/month, plus a separate $69/month program fee — bringing the effective total closer to $168-$268/month depending on which figures apply.

Which states does Livea serve?

Telehealth is limited to Minnesota, Wisconsin, Iowa, and Florida — 4 states. It's primarily a regional clinic network based in MN/WI.

How long has Livea been operating?

Founded in 2011 — 15+ years, with 50,000+ clients served and independent regional recognition (voted Minnesota's Best Weight Loss Program 5 consecutive years).

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.